A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/336 (2006.01) A61K 31/454 (2006.01) A61K 38/18 (2006.01) A61K 38/55 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2307792
The data indicates that the growth of endometrial tissue implanted into the abdominal cavity is suppressed by angiogenesis inhibitors. The dose of TNP-470 used in this pilot study is 1/3 of the established tumor dose.
Les données recueillies à propos de la présente invention permettent de penser qu'il est possible d'utiliser les inhibiteurs de l'angiogenèse pour supprimer la croissance d'un tissu endométrial implanté dans la cavité abdominale. La dose de TNP-470 utilisée pour cette étude pilote est le 1/3 de la dose tumorale établie.
Folkman Judah
Langer Robert S.
Rupnick Maria
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Children's Medical Center Corporation
Massachusetts Institute Of Technology
LandOfFree
Method for regulating size and growth of vascularized normal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for regulating size and growth of vascularized normal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for regulating size and growth of vascularized normal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1424631